Leptin: A Heavyweight Player in Obesity-Related Cancers.

Abstract

Obesity, defined as the abnormal or excessive expansion of white adipose tissue, has reached pandemic proportions and is recognized as an important health concern since it is a common root for several comorbidities, including malignancies. Indeed, the current knowledge of the white adipose tissue, which shifts its role from an energy storage tissue to an important endocrine and metabolic organ, has opened up new avenues for the discovery of obesity's effects on tumor biology. In this review, we will report the epidemiological studies concerning the strong impact of obesity in several types of cancer and describe the mechanisms underlying the heterotypic signals between cancer cell lines and adipocytes, with particular emphasis on inflammation, the insulin/IGF-1 axis, and adipokines. Among the adipokines, we will further describe the in vitro, in vivo, and clinical data concerning the role of leptin, recognized as one of the most important mediators of obesity-associated cancers. In fact, leptin physiologically regulates energy metabolism, appetite, and reproduction, and several studies have also described the role of leptin in affecting cancer development and progression. Finally, we will summarize the newest pharmacological strategies aimed at mitigating the protumorigenic effects of leptin, underlining their mechanisms of action.

• Authors: Amanda Caruso, Luca Gelsomino, Salvatore Panza, Felice Maria Accattatis, Giuseppina Daniela Naimo, Ines Barone, Cinzia Giordano, Stefania Catalano, Sebastiano Andò
• Journal: Biomolecules (Biomolecules) Vol. 13 Issue 7 (07 06 2023) ISSN: 2218-273X [Electronic] Switzerland
• PMID: 37509120 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)

Chemical References

• Leptin
• Adipokines

Topics

• Humans
• Leptin (metabolism)
• Adipose Tissue (metabolism)
• Obesity (complications, metabolism)
• Adipokines (metabolism)
• Neoplasms (metabolism)